VIVS (VivoSim Labs, Inc. Common Stock) Stock Analysis - Politician Trades

VivoSim Labs, Inc. Common Stock (VIVS) is a publicly traded Healthcare sector company. As of May 21, 2026, VIVS trades at $1.24 with a market cap of $3.68M and a P/E ratio of 0.00. VIVS moved +0.00% today. Year to date, VIVS is -33.33%; over the trailing twelve months it is -35.96%. Its 52-week range spans $1.25 to $5.30. Rallies surfaces VIVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded VIVS stock?

Rallies tracks politician and congressional stock disclosures for VIVS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

VIVS Key Metrics

Key financial metrics for VIVS
MetricValue
Price$1.24
Market Cap$3.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.30
52-Week Low$1.25
Volume181.40K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest VIVS News

Recent VIVS Insider Trades

  • Gobel David bought 3.27K (~$7.30K) on Nov 17, 2025.

VIVS Analyst Consensus

VIVS analyst coverage data. Average price target: $0.00.

Common questions about VIVS

Which politicians traded VIVS stock?
Rallies tracks politician and congressional stock disclosures for VIVS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in VIVS?
Yes. Rallies tracks politician and congressional stock disclosures for VIVS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is VIVS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VIVS. It does not provide personalized investment advice.
VIVS

VIVS